Skip to main content
Advanced Technical IVT

immunogenomics

Pronunciation: ih-myoo-noh-juh-NOH-miks

The study of how genomic variations affect immune system function and response to cancer immunotherapy.

Full Definition

Immunogenomics is an interdisciplinary field that examines the relationship between genomic variation and immune system function, with particular relevance to cancer immunotherapy. This field encompasses the analysis of how genetic variants in immune-related genes affect antigen presentation, T-cell recognition, immune checkpoint regulation, and overall immune response to tumors. Key applications include identifying patients likely to respond to checkpoint inhibitors, understanding mechanisms of immune resistance, characterizing tumor immune microenvironments through genomic signatures, and developing personalized immunotherapy approaches. Immunogenomic analysis often involves examining HLA typing, immune gene expression signatures, neoantigen prediction algorithms, and tumor-infiltrating lymphocyte characterization to guide treatment decisions and predict immunotherapy outcomes.

Usage

Usage note: Emerging field with evolving terminology and applications.

In Context

  • "Immunogenomics analysis predicted exceptional response to checkpoint inhibitor therapy." — Case report
  • "The research team developed novel immunogenomics biomarkers for patient stratification." — Research grant application

Also known as

immune genomics

Don't confuse with

immunotherapy immunohistochemistry

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON